PDA

View Full Version : Title iv funds lost - unibe



doctobe1995
03-12-2017, 11:52 AM
As of March 10th, 2017, the school has notified all International Track Students in the Medicine Program that they have lost their Title IV Funds (which include Direct Subsidized/Unsubsidized Loan, Direct Graduate PLUS Loan, Direct PLUS Loan, Federal Pell Grant, Federal Supplemental Educational Opportunity Grant (SEOG), and Federal Perkins Loan).

This was due to the Universidad Iberoamericana's ~71% USMLE passing rate, which does not meet the required 75% for this funding eligibility.

Students who are taking loans out now are either eligible for 2 or 3 more semesters (each semester being 4 months) of these loans until it is officially unavailable.

The school is currently trying to figure out options for students to be able to afford future tuition and will get back to the students in the upcoming weeks.

The following is a spanish news article with a quick summary of the situation.
elnuevodiario.com.do/app/article.aspx?id=524791

Summer2013
03-12-2017, 07:19 PM
That is too bad. It will make it harder for students.

CuentaSecreta
03-16-2017, 02:16 PM
That is too bad. It will make it harder for students.



How so? Make it harder to get into residencies?

Medically Necessary
04-14-2017, 09:47 PM
How so? Make it harder to get into residencies?

Yes, but it’s also gonna be a lot harder for them to pay the tuition. At Unibe it’s like $10-12K a semester. There’s O & M, which is cheaper, but I don’t see anything about scholarships etc. on the website for either school. Plus, I think O & M lost Title IV too. As for Unibe’s USMLE scores…whoa. Pretty sure when I was looking at Caribbean schools Ross, AUA, SGU and others have way better pass rates than that. I got a scholarship from AUA and used loans for the rest. Can you guys transfer here?

jods
05-04-2017, 02:22 PM
my suspicion, the schools passing rate was always below 71%, they were however, exempt from this regulation







Copyright © 2003-2018 ValueMD, LLC. All rights reserved.